Roopa Industries Limited manufactures, markets, and sells bulk drugs and intermediaries in India and internationally. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for the treatment of arthritis; and triphenyl phosphine, which have applications in specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc. that are used in chemical and pharmaceutical industries. The company was incorporated in 1985 and is based in Hyderabad, India.
Metrics to compare | ROOP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipROOPPeersSector | |
---|---|---|---|---|
P/E Ratio | 39.1x | 33.7x | 0.0x | |
PEG Ratio | 1.95 | 0.04 | 0.00 | |
Price/Book | 4.0x | 3.4x | 1.6x | |
Price / LTM Sales | 0.7x | 2.5x | 1.2x | |
Upside (Analyst Target) | - | 7.0% | 39.4% | |
Fair Value Upside | Unlock | −12.9% | 4.6% | Unlock |